Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia

Asian Pacific Journal of Cancer Prevention

Volumn 4, Issue 3, 2003, Pages 225-231

  Nguyen, Anh Minh ^a   Luke, Colin G ^a   Roder, David ^b  

^a DEPARTMENT OF HUMAN SERVICES   (Australia)

^b CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

Author keywords

Histological type; Oesophageal cancer; Secular trends

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; AUSTRALIA; CARDIA; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FEMALE; HUMAN; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; SEXUAL DEVELOPMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; STOMACH TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; AUSTRALIA; CARCINOMA, SQUAMOUS CELL; CARDIA; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; SEX CHARACTERISTICS; STOMACH NEOPLASMS;

EID: 0642340844     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anti-Cancer Foundation of South Australia (ACF) (2001). South Australian Cancer Statistics Monograph No. 1. Cancers of the digestive system. Anti-Cancer Foundation, Adelaide pp 3-6.
2. Armitage P, Berry G (1987). Statistical methods in medical research. Blackwell Scientific Publications, Oxford.
3. Australian Bureau of Statistics (1998). 1996 census of population and housing. Socio-economic indexes for areas. Catalogue no. 2039.0. Australian Bureau of Statistics, Canberra.
4. Cameron AJ, Welborn TA, Zimmet PZ, et al (2003). Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust, 178, 427-32.
5. Cheng KK, Sharp L, McKinney PA, et al (2000). A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer, 83, 127-32.
6. Conio M, Filiberti R, Blanchi S, Giacosa A (2001). Carditis, intestinal metaplasia and adenocarcinoma of the oesophogastric junction. Eur J Cancer Prevention, 10, 483-7.
7. Corley DA, Buffler PA (2001). Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol, 30, 1415-25.
8. EI-Serag HB, Mason AC, Petersen N, Key CR (2002). Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut, 50, 368-72.
9. Fritz A, Percy C, Jack A, et al (eds) (2000). International Classification of Diseases for Oncology. Third Edition. World Health Organization, Geneva.
10. La Vecchia C, Negri E, Lagiou P, Trichopoulos D (2002). Oesophageal adenocarcinoma: a paradigm of mechanical carcinogenesis? Int J Cancer, 102, 269-70.
11. Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999). Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med, 340, 825-31.
12. Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000). The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer, 85, 340-6.
13. Lord RW, Law MG, Ward RL, et al (1998). Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol, 4, 356-62.
14. Nilsson J, Skobe V, Johansson J, Willen R, Johnsson F (2000). Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus. Scand J Gastroenterol, 35, 10-6.
15. Nyren O, Adami H-O (2002). Esophageal cancer. In Adami H-O, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. Oxford University Press, Oxford pp 137-61.
16. Parkin DM, Shanmugaratnam K, Sobin L, Ferlay J, Whelan SL (1998). Histological groups for comparative studies. International Agency for Research on Cancer/International Association of Cancer Registries, Lyon pp 12, 29.
17. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds.) (2002). Cancer Incidence in Five Continents. Vol. VIII. IARC Scientific Publications no. 155. International Agency for Research on Cancer, Lyon.
18. Powell J, McConkey CC, Gillison EW, Spychal RT (2002). Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer, 102, 422-7.
19. Rana PS, Johnston DA (2000). Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance. Dis Esophagus, 13, 28-31.
20. South Australian Cancer Registry (SACR) (2000). Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1999. Incidence and mortality, 1999. Openbook Publishers, Adelaide.
21. South Australian Cancer Registry (SACR) (2001). Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 2000. Incidence and mortality, 2000. Openbook Publishers, Adelaide pp 15-81.
22. Stata Corp (2001). STATA statistical software. Release 7.0. STATA Corporation, College Station, Texas.
23. Suleiman UL, Harrison M, Britton A, McPherson K, Bates T (2000). H2-receptor antagonists may increase the risk of cardiooesophageal adenocarcinoma: a case-control study. Eur J Cancer Prev, 3, 185-91.
24. Todd JA, de Caestecker J (2002). Surgery or endotherapy for highgrade dysplasia/early adenocarcinoma in Barrett's oesophagus? Eur J Gastroenterol Hepatol, 14, 1049-51.
25. van Sandick JW, van Lanschot JJ, Tytgat GN, et al (2001). Barrett oesophagus and adenocarcinoma: an overview of epidemiologic, conceptual and clinical issues. Scand J Gastroenterol (Suppl.), 51-60.
26. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999). Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg, 86, 529-35.
27. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW (2002). Increased incidence of adenocarcinomas of the gastrooesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol, 14, 115-22.